ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk cuts weight-loss drug Wegovy's price by up to 33% in India, document shows
Novo and Lilly are locked in a race for dominance in India, a key battleground for weight-loss treatments in the booming global market, which analysts estimate could be worth 0 billion annually by the end of the decade. "This appears like prices have be
Announcement as on 11 November 2025

Novo Nordisk partners with Emcure to launch weight-loss drug under new brand in India
Novo Nordisk has partnered with Emcure Pharmaceuticals to bring Poviztra, their latest weight-loss medication, to the Indian market. This collaboration builds on Novo Nordisk's prior success with Wegovy and follows Eli Lilly's competition in this space. Af
Announcement as on 10 November 2025

Novo Nordisk ties up with Emcure to expand reach of weight-loss drug semaglutide in India
Novo Nordisk has partnered with Emcure Pharma to distribute and market its diabetes and weight loss injection semaglutide under the brand name Poviztra in India. This collaboration aims to expand access to the drug by leveraging Emcure's extensive distribu
Announcement as on 10 November 2025

Novo Nordisk’s Wegovy could soon have a new sales outlet in the U.S.

Announcement as on 04 November 2025

Novo Nordisk, Eli Lilly fall after Trump vows to lower weight-loss drug costs

Announcement as on 17 October 2025

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 48.11
  • 12Day Average: 48.45
  • 20Day Average: 48.15
  • 50Day Average: 49.83
  • 100Day Average: 52.38
  • 150Day Average: 58.32
  • 200Day Average: 61.02

NVO Indicators & signals

Indicator MACD (12,26,9)

48.38, 48.7, -0.43
Indicator MACD is in negative zone

Indicator ADX (14)

20, 19.75, 29.63
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Mon Dec 2025 48.11 47.59 to 48.84 0% 0.63 times
19 Fri Dec 2025 48.11 46.84 to 48.80 1.03% 0.7 times
18 Thu Dec 2025 47.62 47.52 to 48.31 -0.31% 0.54 times
17 Wed Dec 2025 47.77 47.73 to 48.75 -2.43% 0.67 times
16 Tue Dec 2025 48.96 48.41 to 49.97 -2.8% 1.2 times
15 Mon Dec 2025 50.37 49.55 to 50.66 0.38% 0.96 times
12 Fri Dec 2025 50.18 49.92 to 50.75 -0.22% 1.05 times
11 Thu Dec 2025 50.29 49.59 to 50.54 2.53% 1.32 times
10 Wed Dec 2025 49.05 47.04 to 49.50 5.8% 1.44 times
09 Tue Dec 2025 46.36 46.08 to 46.79 -0.88% 0.87 times
08 Mon Dec 2025 46.77 46.35 to 47.17 -2.26% 1.25 times
05 Fri Dec 2025 47.85 47.83 to 49.15 -0.29% 0.76 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top